콘텐츠로 건너뛰기
Merck

[Drug treatments, from chlorpromazine to new molecules].

Soins. Psychiatrie (2013-06-14)
Adeline Gaillard, Marie-France Poirier
초록

The history of drug treatments, and particularly the discovery of certain molecules, led toan evolution in psychiatric practices. The discovery of the therapeutic properties of chlorpromazine in 1952 by Jean Delay and Pierre Deniker revolutionised the relational process between patients and caregivers.The perspectives are encouraging, notably in the areas of schizophrenia and mood disorders.

MATERIALS
제품 번호
브랜드
제품 설명

Supelco
Chlorpromazine hydrochloride, VETRANAL®, analytical standard
Sigma-Aldrich
Chlorpromazine hydrochloride, ≥98% (TLC)
Sigma-Aldrich
Chlorpromazine hydrochloride, meets USP testing specifications
Supelco
Chlorpromazine hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Chlorpromazine hydrochloride, European Pharmacopoeia (EP) Reference Standard